When an antitumor agent acting on microtubule is used together with an ERK MAP kinase cascade blocking agent, the antitumor effect of the agent acting on microtubule can be remarkably potentiated. Namely, a combination of the agent acting on microtubule with the ERK MAP kinase cascade blocking agent is useful as an excellent antitumor agent with a remarkable efficacy.